在前转移的利基中的中性粒细胞:关键功能和治疗方向
Jiachi Jia1, Yuhang Wang2, Mengjia Li3
1Zhengzhou University, Zhengzhou, 450000, China.
Molecular cancer
|September 14, 2024
概括
瘤细胞在遥远的部位创建前转移性 (PMN). 中性粒细胞是PMN形成的关键,影响瘤生长和复发,提供新的治疗点来阻止转移.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 转移显著导致癌症死亡率和手术后复发.
- 前转移性利基 (PMN) 概念解释了遥远的微环境如何促进瘤细胞的沉积.
- 中性粒细胞是PMN的关键组成部分,塑造其前瘤性特征.
研究的目的:
- 阐明中性粒细胞在前转移性位形成和调节中的作用.
- 审查新兴的治疗策略,针对PMN中的中性粒细胞,以阻止癌症转移.
主要方法:
- 文献综述侧重于中性粒细胞参与PMN发展的机制.
- 对针对中性粒细胞产生抗转移效应的治疗干预措施的当前研究进行分析.
主要成果:
- 中性粒细胞积极重塑PMN微环境,促进免疫抑制,炎症和血管生成.
- 这些由中性粒细胞驱动的变化促进了瘤细胞的移植和远处的进展.
- 针对PMN中的中性粒细胞是一个有前途的策略,可以抑制癌症转移.
结论:
- 中性粒细胞在建立和塑造前转移性利基中起着关键作用.
- 了解PMN中的中性粒细胞功能对于开发新型抗转移疗法至关重要.
- 针对PMN中中性粒细胞介导过程具有显著的治疗潜力,可以改善癌症患者的治疗结果.
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


